Unilever Consumer Care Limited announcements
322 Dhaka Stock Exchange announcements for Unilever Consumer Care Limited (UNILEVERCL) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2020 (30).
- The Board of Directors of DSE has approved the change of name, trading code and sector of the Company will be 'Unilever
The Board of Directors of DSE has approved the change of name, trading code and sector of the Company will be 'Unilever Consumer Care Limited' instead of 'GlaxoSmithKline Bangladesh Limited' and DSE Trading Code for Unilever Consumer Care Limited will be "UNILEVERCL" instead of "GLAXOSMITH" and sector will be "Food & Allied" instead of "Pharmaceuticals and Chemicals" with effect from November 26, 2020. Other things (except name, trading code and sector) will remain unchanged.
Posted under the former code GLAXOSMITH. - (Q3 Un-audited): EPS was Tk. 11.68 for July-September 2020 as against Tk. 21.14 for July-September 2019; EPS was Tk. 38.
(Q3 Un-audited): EPS was Tk. 11.68 for July-September 2020 as against Tk. 21.14 for July-September 2019; EPS was Tk. 38.05 for January-September 2020 as against Tk. 43.39 for January-September 2019 (basic & diluted EPS for the company). NOCFPS was Tk. 44.80 for January-September 2020 as against Tk. 61.72 for January-September 2019. NAV per share was Tk. 117.19 as on September 30, 2020 and Tk. 132.14 as on December 31, 2019 (cont.)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): EPS of the company reduced by 12.3% (38.05 in 2020 vs 43.39 in 2019) This decline has
(Continuation news of GLAXOSMITH): EPS of the company reduced by 12.3% (38.05 in 2020 vs 43.39 in 2019) This decline has resulted from lower sales due to Covid 19, higher inflation in raw material price, increased custom duty on the DMI from 2020 fiscal budget and write off of obsolete ERP system. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2020 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2020.
Posted under the former code GLAXOSMITH. - (Q2 Un-audited): EPS was Tk. 11.40 for April-June 2020 as against Tk. 11.19 for April-June 2019; EPS was Tk. 26.37 for J
(Q2 Un-audited): EPS was Tk. 11.40 for April-June 2020 as against Tk. 11.19 for April-June 2019; EPS was Tk. 26.37 for January-June 2020 as against Tk. 22.25 for January-June 2019. NOCFPS was Tk. 6.49 for January-June 2020 as against Tk. 37.66 for January-June 2019. NAV per share was Tk. 105.51 as on June 30, 2020 and Tk. 72.57 as on June 30, 2019. (cont.1)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): The Company also informed that EPS increased by 18.5% (26.37 in 2020 vs 22.25 in 2019
(Continuation news of GLAXOSMITH): The Company also informed that EPS increased by 18.5% (26.37 in 2020 vs 22.25 in 2019) driven by higher finance income and lower loss from discontinued operation of Pharma business. NAV per share increased by 45.4% compared to 2019 resulted from consistent solid business performance and improved retained earnings. (cont.2)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - (Continuation news of GLAXOSMITH): NOCFPS dropped by 82.7% due to lower sales & collection of receivables caused by the
(Continuation news of GLAXOSMITH): NOCFPS dropped by 82.7% due to lower sales & collection of receivables caused by the COVID-19 lockdown. NOCFPS reflects a significant amount of collections received on account of Pharmaceutical business. Another considerable issue is more streamlined process of trade receivable collection in 2019 resulted in lower opening trade receivable for 2020. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - Mr. Rezaul Haque Chowdhury one of the Independent Directors of the Company, has further reported that he has completed h
Mr. Rezaul Haque Chowdhury one of the Independent Directors of the Company, has further reported that he has completed his sale of 784 shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on 22.07.2020.
Posted under the former code GLAXOSMITH. - Mr. Rezaul Haque Chowdhury one of the Independent Directors of the Company, has expressed his intentions to sell 784 sha
Mr. Rezaul Haque Chowdhury one of the Independent Directors of the Company, has expressed his intentions to sell 784 shares of the Company at prevailing market price (In the Public market) through Stock Exchange (DSE) within next 30 working days.
Posted under the former code GLAXOSMITH. - Trading of the Shares of the Company will resume on 23.07.2020 after record date.
Trading of the Shares of the Company will resume on 23.07.2020 after record date.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will remain suspended on record date i.e., 22.07.2020 for EGM.
Trading of the shares of the Company will remain suspended on record date i.e., 22.07.2020 for EGM.
Posted under the former code GLAXOSMITH. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 27, 2020 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on June 30, 2020.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle from 20.07.2020 to 21.07.2020. Trading of the shares of the Company will remain suspended on record date i.e., 22.07.2020 for EGM.
Posted under the former code GLAXOSMITH. - Uniliver Overseas Holdings B.V., has further reported that it has completed its buy of 98,75,144 shares (Share acquisiti
Uniliver Overseas Holdings B.V., has further reported that it has completed its buy of 98,75,144 shares (Share acquisition) of the Company at prevailing market price (In the Block market) through Stock Exchange as per declaration disseminated on 25.06.2020
Posted under the former code GLAXOSMITH. - The Board of Directors has recommended to change the name of the Company GlaxoSmithKline Bangladesh Limited to Unilever
The Board of Directors has recommended to change the name of the Company GlaxoSmithKline Bangladesh Limited to Unilever Consumer Care Limited subject to obtaining approval from RJSC&F, members approval in EGM and other applicable regulatory approval. Date of EGM: 16.08.2020, Time of EGM: 11:00 AM, Venue of EGM: Digital Platform. Record Date for EGM: 22.07.2020.
Posted under the former code GLAXOSMITH. - SETFIRST Limited, one of the Corporate Directors of the Company, has further reported that it has completed its sale of
SETFIRST Limited, one of the Corporate Directors of the Company, has further reported that it has completed its sale of 98,75,144 shares of the Company at prevailing market price (In the Block market) through Stock Exchange as per declaration disseminated on 25.06.2020.
Posted under the former code GLAXOSMITH. - The Company has informed that, in its 296th Board meeting, the Board of Directors of the company has elected Mr. Masud K
The Company has informed that, in its 296th Board meeting, the Board of Directors of the company has elected Mr. Masud Khan as Chairman of the Company along with position of some new Board Members.
Posted under the former code GLAXOSMITH. - The Company has informed that Mr. Khan Salahuddin Mohammad Minhaj has been appointed as the Managing Director of the Com
The Company has informed that Mr. Khan Salahuddin Mohammad Minhaj has been appointed as the Managing Director of the Company subject to the approval of the members in General meeting with effect from 1st July 2020.
Posted under the former code GLAXOSMITH. - Refer to their earlier news disseminated by DSE on 04.12.2018 and 23.03.2020 regarding "Sale of entire Shareholding of S
Refer to their earlier news disseminated by DSE on 04.12.2018 and 23.03.2020 regarding "Sale of entire Shareholding of SETFIRST Limited (Setfirst)", a shareholder of the Company holding 9,875,144 shares, the Company has further informed that the Board of Directors were informed on 24.06.2020 vide a notification letter dated 24.06.2020 ( the "Setfirst Letter") from SETFIRST Limited ("Setfirst"), the majority shareholder/member of the Company, informing the Company that (Cont. 1)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH) in furtherance to intention to sell its entire shareholding in the Company to Uniliver
(Continuation news of GLAXOSMITH) in furtherance to intention to sell its entire shareholding in the Company to Uniliver N.V (i) The Conditions for the Transaction have been fulfilled (ii) the Transaction have been approved by the Board of Directors of Setfirst and (iii) the Setfirst has therefore decided to proceed with executing the Transaction. (Cont 2)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - (Continuation news of GLAXOSMITH) They also informed that the designated purchaser of the sale of shares was later chang
(Continuation news of GLAXOSMITH) They also informed that the designated purchaser of the sale of shares was later changed from Uniliver N.V to Uniliver Overseas Holdings B.V. which was informed accordingly. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - SETFIRST Limited, one of the Corporate Directors of the Company, has expressed its intention to sell its entire holding
SETFIRST Limited, one of the Corporate Directors of the Company, has expressed its intention to sell its entire holding 98,75,144 shares of the Company at prevailing market price (In the Block market) in compliance of BSEC Order No. BSEC/CMRRCD/2001-07/04 dated March 19, 2020, whereas Uniliver Overseas Holdings B.V. another Corporate entity, (cont.)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): has expressed its intention to buy 98,75,144 shares at prevailing market price (In th
(Continuation news of GLAXOSMITH): has expressed its intention to buy 98,75,144 shares at prevailing market price (In the Block market) through Stock Exchange (DSE) within next 30 working days, as per Rule-4 of the BSEC (Substantial Acquisition of shares and Takeovers), Rules, 2018. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - (Q1 Un-audited): EPS was Tk. 14.97 for January-March 2020 as against Tk. 11.06 for January-March 2019; NOCFPS was Tk. 0.
(Q1 Un-audited): EPS was Tk. 14.97 for January-March 2020 as against Tk. 11.06 for January-March 2019; NOCFPS was Tk. 0.71 for January-March 2020 as against Tk. 28.29 for January-March 2019. NAV per share was Tk. 147.12 as on March 31, 2020 and Tk. 115.16 as on March 31, 2019.
Posted under the former code GLAXOSMITH. - Refer to their earlier news disseminated by DSE on 04.12.2018 regarding "Sale of entire Shareholding of SETFIRST Limited
Refer to their earlier news disseminated by DSE on 04.12.2018 regarding "Sale of entire Shareholding of SETFIRST Limited (Setfirst)", a shareholder of the Company holding 9,875,144 shares, has further informed that the sale shares held by Setfirst in the Company will be acquired by "Unilever Overseas Holdings B.V" instead of "Unilever N.V".
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will remain suspended on record date i.e., 16.03.2020.
Trading of the shares of the Company will remain suspended on record date i.e., 16.03.2020.
Posted under the former code GLAXOSMITH. - The Board of Directors has recommended 530% cash dividend for the year ended on December 31, 2019. Date of AGM: 16.04.20
The Board of Directors has recommended 530% cash dividend for the year ended on December 31, 2019. Date of AGM: 16.04.2020, Time: 11:00 AM, Venue: Radisson Blu Chattogram Bay view, Chattogram. Record date: 16.03.2020. The Company has also reported EPS of Tk. 81.83, NAV per share of Tk. 132.14 and NOCFPS of Tk. 82.84 for the year ended on December 31, 2019 as against Tk. (52.75), Tk. 104.11 and Tk. 44.67 respectively for the same period of the previous year.
Posted under the former code GLAXOSMITH. - There will be no price limit on the trading of the shares of the Company today (25.02.2020) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (25.02.2020) following its corporate declaration.
Posted under the former code GLAXOSMITH. - The Company has further informed that reasons for significant deviation of Earnings per Share (EPS): in the year 2018, t
The Company has further informed that reasons for significant deviation of Earnings per Share (EPS): in the year 2018, there were significant costs incurred for severance payment to employees and decommissioning of Chittagong Factory due to closure of Pharmaceutical business of GlaxoSmithKline Bangladesh Limited resulting EPS of Tk. (52.75). In 2019, the impact of discontinued business was minimal and the Company achieved desired level of EPS through several cost saving activities.
Posted under the former code GLAXOSMITH. - As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 24, 2020 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2019.
Posted under the former code GLAXOSMITH.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.